Results 211 to 220 of about 27,664 (266)
Epidemiology and Risk Factor Analysis of Systemic Allergic Reaction to Bee Venom in the Slovenian Population of Beekeepers. [PDF]
Zdr VarstCarli T +4 more
europepmc +1 more source
Effects of bee venom and melittin on cell response of tumor and non-tumor cells in vitro
, 2012 Goran Gajski
openalex
Selective anastasis induction by bee venom in normal cells: a promising strategy for breast cancer therapy with minimal impact on cell viability. [PDF]
J Zhejiang Univ Sci BTetikoglu S +3 more
europepmc +1 more source
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation. [PDF]
Sci RepBadivi S +6 more
europepmc +1 more source
Bee venom: A potential natural alternative to conventional preservatives for prolonging the shelf-life of soft cheese 'Talaga'. [PDF]
HeliyonAhmed MBM +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Reviews in Allergy & Immunology, 2017
Bee venom is a blend of biochemicals ranging from small peptides and enzymes to biogenic amines. It is capable of triggering severe immunologic reactions owing to its allergenic fraction. Venom components are presented to the T cells by antigen-presenting cells within the skin.
Daniel, Elieh Ali Komi +2 more
openaire +4 more sources
Bee venom is a blend of biochemicals ranging from small peptides and enzymes to biogenic amines. It is capable of triggering severe immunologic reactions owing to its allergenic fraction. Venom components are presented to the T cells by antigen-presenting cells within the skin.
Daniel, Elieh Ali Komi +2 more
openaire +4 more sources
Cancer and Metastasis Reviews, 2011
Bee venom (BV) (api-toxin) has been widely used in the treatment of some immune-related diseases, as well as in recent times in treatment of tumors. Several cancer cells, including renal, lung, liver, prostate, bladder, and mammary cancer cells as well as leukemia cells, can be targets of bee venom peptides such as melittin and phospholipase A2.
Nada Oršolić
openaire +6 more sources
Bee venom (BV) (api-toxin) has been widely used in the treatment of some immune-related diseases, as well as in recent times in treatment of tumors. Several cancer cells, including renal, lung, liver, prostate, bladder, and mammary cancer cells as well as leukemia cells, can be targets of bee venom peptides such as melittin and phospholipase A2.
Nada Oršolić
openaire +6 more sources
Medical Journal of Australia, 1980
To the Editor.— Regarding the COMMENTARY by Lichtenstein et al elsewhere in this issue (p 1683), the basic question is can one justify immunotherapy to protect against the following: 1. A disease with an almost zero mortality when those at mortal risk have not been identified?
openaire +3 more sources
To the Editor.— Regarding the COMMENTARY by Lichtenstein et al elsewhere in this issue (p 1683), the basic question is can one justify immunotherapy to protect against the following: 1. A disease with an almost zero mortality when those at mortal risk have not been identified?
openaire +3 more sources